Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma.
Stefanie MeyerDiana HandkeAnja MuellerKatharina BiehlMarkus KreuzJürgen BukurUlrike KoehlMaria-Filothei LazaridouMark BerneburgAndré StevenChiara MassaBarbara SeligerPublished in: Cancers (2021)
The heterogeneous basal expression of HLA class II antigens and/or APM components in melanoma cells is caused by distinct molecular mechanisms and has clinical relevance.